Neopharma commenced operations in 2003 and the first set of manufacturing facilities were planned on an investment outlay of USD25 million. The organization’s inspiration stems from the vision to locally manufacture world class pharmaceuticals at affordable prices.
Spread over an area of 100,000 square meters, the plant encompasses two independent production blocks. One is dedicated towards manufacturing general products and the other is an exclusive centre for manufacturing ‘Betalactam’ products. Furthermore, the plant has an exclusive area for R&D. The company lays strong emphasis on research, especially towards development of processes and products that are patent non-infringing.
“To progress into a globally admired and technology driven ‘integrated healthcare enterprise’, which shall continually innovate and adapt to deliver the best in healthcare.”
Neopharma, a brand that is rapidly expanding its global footprint.
Is part of the giant NMC group and offers complete end-to-end support to its partners.
‘Innovation’ is strongly embedded into the DNA of Neopharma.
Addresses the needs of the marketplace with the right products at affordable prices.